RPAP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.117400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.866800E-01
Normal-vs-Stage2
3.203400E-01
Normal-vs-Stage3
5.135700E-02
Normal-vs-Stage4
5.350200E-01
Stage1-vs-Stage2
7.278400E-01
Stage1-vs-Stage3
3.723700E-02
Stage1-vs-Stage4
9.574800E-01
Stage2-vs-Stage3
1.215790E-01
Stage2-vs-Stage4
7.410800E-01
Stage3-vs-Stage4
9.753800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.216400E-01
Normal-vs-AfricanAmerican
5.848200E-01
Normal-vs-Asian
2.164600E-01
Caucasian-vs-AfricanAmerican
6.932000E-01
Caucasian-vs-Asian
4.497800E-01
AfricanAmerican-vs-Asian
4.462400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.188800E-01
Normal-vs-Female
2.048200E-01
Male-vs-Female
2.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.716200E-01
Normal-vs-Age(41-60Yrs)
7.262000E-01
Normal-vs-Age(61-80Yrs)
1.776570E-01
Normal-vs-Age(81-100Yrs)
2.481800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.067970E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.680800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.669800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.771600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.471790E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.445000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.017780E-01
Normal-vs-Daily Drinker
1.055560E-01
Normal-vs-Weekly Drinker
1.202970E-01
Normal-vs-Occasional Drinker
8.561800E-01
Normal-vs-Social Drinker
2.844200E-01
Non Drinker-vs-Daily Drinker
6.524200E-01
Non Drinker-vs-Weekly Drinker
6.654600E-01
Non Drinker-vs-Occasional Drinker
1.998310E-02
Non Drinker-vs-Social Drinker
4.209200E-01
Daily Drinker-vs-Weekly Drinker
9.745400E-01
Daily Drinker-vs-Occasional Drinker
1.923740E-02
Daily Drinker-vs-Social Drinker
2.880200E-01
Weekly Drinker-vs-Occasional Drinker
4.057700E-02
Weekly Drinker-vs-Social Drinker
3.235200E-01
Occasional Drinker-vs-Social Drinker
1.993210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.681200E-01
Normal-vs-Grade 2
1.982600E-01
Normal-vs-Grade 3
6.401600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.352400E-01
Grade 1-vs-Grade 3
8.897200E-01
Grade 1-vs-Grade 4
2.681200E-01
Grade 2-vs-Grade 3
6.547800E-01
Grade 2-vs-Grade 4
1.982600E-01
Grade 3-vs-Grade 4
6.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.427840E-01
Normal-vs-NonDiabetic
2.496000E-01
Diabetic-vs-NonDiabetic
4.569200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.981700E-02
Normal-vs-NoPancreatitis
2.634400E-01
Pancreatitis-vs-NoPancreatitis
3.691800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.026400E-01
Normal-vs-N1
3.180800E-01
N0-vs-N1
9.690200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.326000E-01
Normal-vs-TP53-NonMutant
5.164600E-01
TP53-Mutant-vs-TP53-NonMutant
3.911600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
